The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies

Abstract

AimsDepression is a common co-morbidity in patients with type 2 diabetes mellitus (T2DM). Untreated depression in these patients adversely affects self-care activities and other diabetes complications. The aim of this study is to estimate the prevalence of depression among patients with T2DM by conducting a meta-analysis of observational studies.MethodsMEDLINE, Web of Science, Science Direct, and Google Scholar databases were searched for all observational studies that assessed depression in T2DM. Relevant articles were searched using the combination of Medical Subject Heading (MeSH) terms of depression, depressive disorder, and diabetes mellitus published between January 2007 and July 2018. Random effects model was used to estimate the weighted prevalence rates and 95 CI using metaprop program in STATA 11.ResultsIn total, the 248 included studies (with 273 reported prevalence) identified 83,020,812 participants; of them, 23,245,827 (28; 95 CI 27, 29) suffered from different severity levels of depressive disorders. The prevalence of depression was separately reported in 137,372 males and 134,332 females. Of them, 31,396 males (23, 95 CI: 20, 26) and 45,673 females (34, 95 CI: 31, 38) were depressed. Compared with global estimate, depression prevalence was lower in Europe (24) and Africa (27), but higher in Australia (29) and Asia (32). The prevalence in America was equal to the estimated prevalence in the world (28). Depression was more common in subjects younger than 65 compared with elderlies (31 vs. 21).ConclusionOur findings demonstrated that almost one in four adults with T2DM experienced depression. Given the high prevalence of depressive disorders in diabetic patients, screening these patients for co-morbid depression and its relevant risk factors is highly recommended.